News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tissue Regenix Ltd - First Day of Dealings


6/29/2010 2:31:37 PM

Tissue Regenix, (AIM: TRX) a medical technology company focused on the development and commercialisation of acellular tissue replacement products to address the chronic global shortfalls in donor tissue availability, announces that it has joined the AIM market of the London Stock Exchange today via a reverse takeover of Oxeco Plc. This follows the passing on 28 June 2010 of the resolutions relating to Oxeco's acquisition of Tissue Regenix Ltd.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES